Sahng W. Park
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Limitations of Ferroptosis Inhibitors on the Doxorubicin-Induced Cardiotoxicity.
Journal: Antioxidants (Basel, Switzerland)
Published: November 15, 2025
MicroRNA-1912 regulates cholesterol homeostasis by targeting PCSK9.
Journal: Molecular therapy. Nucleic acids
Published: December 17, 2024
Generation of an induced pluripotent stem cell line from a patient with arrhythmogenic right ventricular cardiomyopathy harboring a TMEM43 splice-site variant.
Journal: Stem cell research
Published: March 26, 2024
Hydroethanolic extract of Cirsium setidens ameliorates doxorubicin-induced cardiotoxicity by AMPK-PGC-1α-SOD-mediated mitochondrial protection.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: November 16, 2023
Inhibition of TBL1 cleavage alleviates doxorubicin-induced cardiomyocytes death by regulating the Wnt/β-catenin signal pathway.
Journal: Cardiovascular research
Published: May 23, 2023
Human induced pluripotent stem cell line YCMi007-A generated from a dilated cardiomyopathy patient with a heterozygous dominant c.613C > T (p. Arg205Trp) variant of the TNNT2 gene.
Journal: Stem cell research
Published: November 21, 2022
An induced pluripotent stem cell line (YCMi006-A) generated from a patient with hypertrophic cardiomyopathy who carries the ACTA1 mutation p.Ile343Met.
Journal: Stem cell research
Published: June 19, 2022
Derivation of YCMi005-A, a human-induced pluripotent stem cell line, from a patient with dilated cardiomyopathy carrying missense variant in TPM1 (p. Glu192Lys).
Journal: Stem cell research
Published: December 15, 2021
Generation of a human induced pluripotent stem cell line YCMi004-A from a patient with dilated cardiomyopathy carrying a protein-truncating mutation of the Titin gene and its differentiation towards cardiomyocytes.
Journal: Stem cell research
Published: October 11, 2021
Establishment of a novel human iPSC line (YCMi003-A) from a patient with dilated cardiomyopathy carrying genetic variant LMNA p.Asp364His.
Journal: Stem cell research
Published: July 12, 2021
Piceatannol reduces resistance to statins in hypercholesterolemia by reducing PCSK9 expression through p300 acetyltransferase inhibition.
Journal: Pharmacological research
Published: July 21, 2020
Last Updated: 09/26/2026